Shows / Conversations with CEI
Conversations with CEI
Conversations with Clinical Education Initiative (CEI) features clinical experts in HIV Primary Care and Prevention, Sexual Health, Hepatitis C and Drug User Health. Our episodes feature CEI clinicians’ experience and insight on the current health issues, alongside the latest news and guidelines on our areas of expertise.
This podcast is produced by the CEI, a New York State Department of Health AIDS Institute program.
Episodes
Conversations with CEICardiovascular Health in People Who Use Stimulants
Drawing on recent New York State data and clinical experience, this episode explores the growing impact of cocaine and methamphetamine use, the risks of…
Conversations with CEIThree New Two-Drug Regimens: Which Problem Does Each One Solve?
In this episode, Dr. Antonio E. Urbina, Medical Director for CEI’s HIV Primary Care and Prevention Center of Excellence, provides an overview of three new…
Conversations with CEIDitching the Script: Person-Centered Contraceptive Counseling
Erica Bostick, MD is joined by guest speaker Susan Wiener, MD, MPH for this episode of “Conversations with CEI.” Dr. Susan Wiener is an Assistant Professor of…
Conversations with CEIAnabolic Androgenic Steroids: Is “The Cycle” Addictive?
Anabolic androgenic steroids (AAS) are synthetic versions of testosterone, and like naturally produced testosterone, they can increase male sex characteristics…
Conversations with CEIAIDS 2026 in Rio: What Came Out of the 26th International AIDS Conference
AIDS 2026, the 26th International AIDS Conference, was held on July 26-31 in Rio. In this episode, Dr. Antonio E. Urbina, Medical Director for CEI’s HIV…
Conversations with CEIUpdates on HSV Infection
Daniela DiMarco, MD, MPH is joined by guest speaker Valeria Cantos, MD for this episode of “Conversations with CEI.” Dr. Valeria Cantos is an Associate…
Conversations with CEIBeyond the Script: Applying Harm Reduction Principles in Practice
Communication and relationship building are key approaches to harm reduction that focus on meeting people where they are. Both rely on shifting away from…
Conversations with CEICardiovascular Risk in People with HIV: New Risk Equations, New Guidelines, and Who Gets a Statin
The 2026 ACC/AHA/Multisociety Dyslipidemia Guideline recommends statin therapy for primary prevention of ASCVD for all people living with HIV (PLHIV) aged 40…
Conversations with CEIBest of the Best: Practice-Changing Papers in STI Care from 2025
Hosts Margie Urban, MD, and Daniela DiMarco, MD, MPH, are joined by Jason Zucker, MD. Dr. Zucker is an Assistant Professor of Medicine at the Columbia…
Conversations with CEICompassion, Choice and Curiosity: Harm Reduction in Practice
Harm reduction is a set of practical strategies and ideas aimed at reducing negative consequences associated with drug use. It is also a movement for social…
Conversations with CEICloser to a Cure? New HIV Cure Research from Stem Cell Transplants to CAR-T Cell Therapy
Two recent studies have shown remarkable advances in HIV cure research: (1) a Norwegian man who achieved long-term HIV remission after a stem cell transplant…
Conversations with CEIASSETS-NY – Anal Dysplasia Screening, Surveillance, Education and Treatment Services of NY
Host Marguerite Urban, MD is joined by William DeWitt, MD, Clinical Director of Anal Health in Primary Care at Northwell Health, to discuss a new coalition…
Conversations with CEIIntroducing Point-of-Care Testing for Hepatitis C
New York State’s Hepatitis C Dashboard shows that in 2023, 4,783 people were newly diagnosed with HCV in the state, an 8% decrease from 2022. Incidence also…
Conversations with CEICannabis and Pregnancy
Based on data from 2023-24, roughly 23% of New Yorkers aged 21 or older reported cannabis use in the past 12 months. Although men generally have a higher…
Conversations with CEICROI 2026 – Live from Denver: What You Need to Know
Conference on Retroviruses and Opportunistic Infections (CROI) 2026 took place from February 22 to 25 in Denver, Colorado. CROI is an annual scientific meeting…
Conversations with CEIMisconceptions about Contraception
Host Dr. Erica Bostick from the University of Rochester Medical Center Division of Adolescent Medicine chats with Dr. Stacy Sun, a double board-certified…
Conversations with CEIWhat “The 72-Hour Rule” Update Means for New York State
Effective February 19, 2026, New York State law permits clinicians to dispense up to 72 hours (equivalent to a 3-day supply) of controlled substances, such as…
Conversations with CEITwo New Treatments for Gonorrhea; one is available now!
In this episode of the Conversations with CEI, infectious disease specialist Dr. Steven Fine delves into groundbreaking advancements in the treatment of…
Conversations with CEIPrEParing for Lenacapavir Implementation in Your Clinic: Early Lessons Learned
On June 18, 2025, the FDA approved Yeztugo, the brand name for subcutaneous lenacapavir, a prescription medication used for the pre-exposure prophylaxis of…
Conversations with CEIKeeping an Eye on STIs – Have You Heard of TMVII?
This month, host Dr. Marguerite Urban chats with Dr. Jason Zucker, an adult and pediatric infectious diseases physician at Columbia University and the…
Conversations with CEIRecap of the 2025 Annual New York State Hepatitis C and Drug User Health Conference
On September 9th, CEI hosted its first in-person conference dedicated to hepatitis C and drug user health. A group of New York State-based clinicians met in…
Conversations with CEIInsights from the 13th International AIDS Society Conference on HIV Science
In this episode of Conversations with CEI, Dr. Steven Fine unpacks some of the latest developments and research presented at the 2025 International AIDS…
Conversations with CEIEvolving Landscape of Geriatric HIV Care
The demographics of HIV care are rapidly changing, and with them, the clinical needs of patients aging with HIV. In this episode, host Dr. Tony Urbina, Medical…
Conversations with CEIHighlights and Perspectives from the 11th Annual NYS Sexual Health Conference
Live from Canandaigua…it’s the 11th Annual NYS Sexual Health Conference! The CEI Sexual Health Center of Excellence hosted the 11th Annual NYS Sexual Health…
Conversations with CEIXylazine & Medetomidine & Nitazines, Oh My! An Update on New York State’s Drug Supply
New York drug overdose deaths and death rates are on the decline, but with significant disparities and the current, toxic drug supply is partially to blame…
Conversations with CEICEI…we got you! Evolving with the Science
In this episode of Conversations with CEI, we engage with CEI’s clinicians, researchers, and public health experts to explore current and emerging issues in…
Conversations with CEINavigating Measles Vaccine Recommendations for Patients with HIV
In light of the increase in measles cases within the United States, this episode features Dr. Steven Fine, an infectious disease expert, who offers a…
Conversations with CEIThe Invisible Latino HIV Crisis
In May 2024, the Centers for Disease Control and Prevention (CDC) released its annual HIV surveillance reports. The new data show a continuation of…
Conversations with CEIUpdates in Syphilis: Looking Back to Look Forward
Let’s dive in! This month, we welcome new hosts Patrick Passarelli, MD, an infectious diseases fellow at the University of Rochester, and Nicholas Gerbino, a…
Conversations with CEIThe Role of Opioid Treatment Programs in Hepatitis C Care: A Path to Elimination
Between 2010 and 2022 (the latest year for which data are available), 194,375 New Yorkers were diagnosed with hepatitis C (HCV) and of those, 53% (103,213…
Conversations with CEIUse of Injectable Cabotegravir for HIV PrEP in Pregnancy
This podcast outlines some of the data presented at the 25th International AIDS Conference from HPTN 084 as it pertains to using injectable cabotegravir for…
Conversations with CEICompassionate Care for LGBTQ+ Individuals Struggling with Substance Use Disorder
Research suggests that LGBTQ adults have higher rates of substance use and mental health issues, compared to their heterosexual cisgender peers. These health…
Conversations with CEIReflections from the 2024 CDC STI Prevention Conference
For the first time since 2018 and since the COVID-19 pandemic, the Centers for Disease Control and Prevention hosted their biennial STI Prevention Conference…
Conversations with CEIThe Case for Chronic Pain Management among People Who Use Opioids
Are current guidelines failing chronic pain patients with a history of substance-use disorders? Find out why Dr. Wang and Dr. Kelly are calling for urgent…
Conversations with CEIAn Exciting New Twice-yearly Option for HIV PrEP
“This podcast discusses the recent presentation of data for lenacapavir, a potent capsid inhibitor for HIV that was 100% effective in preventing HIV infection…
Conversations with CEIWhen HIV Tests Perplex: Expert Insights on Ambiguous and Discordant Results
Providers calling into our CEI hotline often ask me what to do when their patient's HIV test results are unclear. These ambiguous or discordant test results…
Conversations with CEIIt’s Complicated…but Necessary! Navigating Confidential Sexual Healthcare for Adolescents
“Nobody goes into adolescent medicine or into a field of medicine that serves adolescent patients because it’s simple and straightforward, right?” In May 2024…
Conversations with CEISpecial Conversations with CEI: Best Practices for Hepatitis C and Pregnancy Screening: Advice from a Fellow Clinician
Hepatitis C virus (HCV) is a pathogen spread by contact with blood from a person with HCV infection. Prevalence among the US obstetric population rose nearly…
Conversations with CEISpecial Conversations with CEI: Best Practices for Working with People Who Use Substances
Hepatitis C virus (HCV) is a pathogen spread by contact with blood from a person with HCV infection. Prevalence among the US obstetric population rose nearly…
Conversations with CEISpecial Conversations with CEI: The Impact of Hepatitis C Screening during Pregnancy: A Client’s Story
Hepatitis C virus (HCV) is a pathogen spread by contact with blood from a person with HCV infection. Prevalence among the US obstetric population rose nearly…
Conversations with CEIWould you consider Injectable ART for those unable to suppress with oral HIV treatment?
In this episode, Dr. Steven Fine discusses some of the latest data that might be used to support starting patients who are unable to take oral antiretroviral…
Conversations with CEIHIV Prevention Research in the Kink-Involved Population
Cultural humility in healthcare, especially for those involved in kink, requires going beyond basic competence. Clinicians must provide respectful care…
Conversations with CEIDoxy-PEP Part II: Where Are We Now?
In this episode, Dr. Marguerite Urban and Dr. Daniela DiMarco pick up from the November 2023 episode of Conversations with CEI, where they talked about…
Conversations with CEITackling Stigma with Compassion: Harm Reduction in Clinical Practice
Harm reduction is a set of practical strategies and ideas aimed at reducing negative consequences associated with drug use. It is also a movement for social…
Conversations with CEIRSV Vaccination in HIV Positive Adults
RSV vaccine for adults has recently become available and can protect against severe disease or death from one of the main causes of upper respiratory…
Conversations with CEIWe can do it! Improving access to care for transgender and gender diverse patients
Compared with the general population, transgender and gender diverse people are more likely to experience poor health outcomes, such as chronic health…
Conversations with CEIWhat is Doxy-PEP? A Conversation about the Use of Doxycycline Post Exposure Prophylaxis to Prevent STIs
In this episode, Dr. Marguerite Urban and Dr. Daniela DiMarco discuss Doxy-PEP, a new tool for the prevention of bacterial STIs. Drs. Urban and DiMarco are…
Conversations with CEISafe and Safer Supply for People Who Use Drugs
The United States is in the midst of an overdose crisis that’s been exacerbated by the COVID-19 pandemic and increased toxicity of the drug supply, largely a…
Conversations with CEIREPRIEVE: Pitavastatin to Prevent Cardiovascular Disease in HIV
HIV patients are known to have up to a two-fold increase in heart-related events, compared with the general population. Could treatment with statins reduce…
Conversations with CEIMaking a SPLASH! Long-acting Injectables for vulnerable populations with HIV
The clinical innovation of antiretroviral treatment for HIV is a major public health victory that has transformed the shape of the epidemic. Healthcare…
Conversations with CEITackling Syphilis: A Conversation with the New York State Department of Health AIDS Institute Office of Sexual Health and Epidemiology
In this episode, Dr. Marguerite Urban chats with Drs. Rachel Hart-Malloy and Wilson Miranda from the New York State Department of Health AIDS Institute Office…
Conversations with CEIIntegrating Hepatitis C Treatment into Opioid Treatment Programs: The Greenwich House Story
Hepatitis C virus (HCV) infection is a major public health problem responsible for substantial morbidity, including cirrhosis and liver cancer, and mortality…
Conversations with CEITalking to patients about Lenacapavir (Sunlenca); the new long-acting injectable medication for HIV
In this episode, Dr. Steven Fine, an infectious disease specialist affiliated with the University of Rochester and Anthony Jordan Health Center explains the…
Conversations with CEIProviding Affirming Care to Transgender Youth
One recent study shows that only 4% of trans youth with supportive parents attempted suicide, while 57% with unsupportive parents committed suicide… In the…
Conversations with CEIThe Resurgence of Congenital Syphilis in NYS: A Look at the Past and Present to Change the Future
In this episode host Melinda Godfrey, a Nurse Practitioner at the University of Rochester, and Program Manager of the Congenital Syphilis Prevention Project…
Conversations with CEIWhat We Know About Xylazine
In this episode host Lauren Walker, Program Director for the Hep C and Drug User Health Center of Excellence at CEI, speaks with special guests Dr. Sharon…
Conversations with CEISTART Trial Update
This podcast is about a long term follow up to the START trial which originally showed that starting antiretroviral therapy even at high CD4 counts (above 500)…
Conversations with CEIHow Can We Destigmatize HIV and Pregnancy?
Preventing perinatal HIV transmission is an important strategy for eliminating HIV. Historically, rates of perinatal HIV transmission were 25-40% without…
Conversations with CEITaking the Next Step: Providing Proactive Reproductive Health Care in Your Clinical Setting
Reproductive healthcare is a critical part of healthcare overall. Yet components of this care, including abortion, are becoming more and more inaccessible to…
Conversations with CEIUniversal Hepatitis C Screening among Pregnant Persons: The Time is Now
Hepatitis C is the most commonly reported blood-borne infection in the US, responsible for more deaths than all 60 reportable infectious diseases combined…